Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lisa A Millar"'
Autor:
Lisa A Millar, Levent Gülen, M. Kahraman, Victoria Lane, David Thompson, Sebastian Rost, Selda Altuncu Poyraz, U. Teoman, Murat Utkucu, Niyazi Türkelli, David G. Cornwell, Elodie Kendall, Gregory A. Houseman
Shear wave splitting measurements across the North Anatolian Fault (NAF) in Northern Turkey are calculated from teleseismic SKS arrivals recorded by the dense temporary DANA seismological array to ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b5657a017f9f96ef3b9003fa9c0b773
https://doi.org/10.1002/essoar.10505730.1
https://doi.org/10.1002/essoar.10505730.1
Autor:
Stephen D. Mikolajczyk, Harry J. Linton, Harry G. Rittenhouse, Lisa S. Millar, Christine L. Knott, Leonard S. Marks
Publikováno v:
Clinical Chemistry. 49:253-259
Background: BPSA is a “benign” form of free prostate-specific antigen (PSA) that is increased in prostate transition zone tissues of men with pathologic benign prostatic hyperplasia (BPH). We developed an immunoassay to determine the concentratio
Autor:
Stephen D. Mikolajczyk, Marcia K. Goodmanson, Robert Carlson, Cindy L. Evans, Harry G. Rittenhouse, Lisa S. Millar, Kristine Kuus-Reichel, George G. Klee, Judith A. Finlay, John R Day
Publikováno v:
Clinical Chemistry. 47:1218-1224
Background: Human kallikrein 2 (hK2) shares 80% sequence identity with prostate-specific antigen (PSA). Because both hK2 and hK2-α1-antichymotrypsin (hK2-ACT) complexes have been identified in patient sera, we devised an immunoassay for total hK2 [(
Publikováno v:
European Journal of Biochemistry. 267:4040-4045
We previously identified a modified molecular form of prostate-specific antigen that is significantly elevated in the nodular transition zone tissue of prostates with benign prostatic hyperplasia. This prostate-specific antigen form, designated BPSA,
Publikováno v:
The Prostate. 44:248-254
BACKGROUND Human prostate-specific antigen (PSA) and human kallikrein 2 (hK2) are expressed primarily by prostate epithelial cells. PSA and hK2 both exist as free protein and complexed with protease inhibitors (e.g., α1-antichymotrypsin, ACT) in ser
Autor:
Leonard S. Marks, Harry G. Rittenhouse, Lisa S. Millar, Stephen D. Mikolajczyk, Kevin M. Slawin, Weitao Song, Robert L. Wolfert, Tang J. Wang, Thomas M. Wheeler
Publikováno v:
Urology. 55:41-45
Objectives. The biologic mechanism for the increased proportion of noncomplexed (“free”) prostate-specific antigen (PSA) found in the serum of patients with benign prostate disease is unknown. We recently reported that most of the PSA found in be
Publikováno v:
The Prostate. 34:44-50
BACKGROUND Human glandular kallikrein (hK2) is a new potential marker for prostate cancer. It is a serine protease expressed in human prostate epithelial cells which has 78% sequence identity with prostate-specific antigen (PSA). PSA is a widely used
Autor:
Stephen D. Mikolajczyk, Lana S. Grauer, Abhay Kumar, Amita S. Goel, Michelle M. J. Cass, Mohammad S. Saedi, Kathy M. Marker, Lisa S. Millar
Publikováno v:
European Journal of Biochemistry. 246:440-446
Prostate-specific human kallikrein, hK2, is a serine protease found in prostate tissues that has 78% amino acid sequence identity with prostate-specific antigen (PSA). We have previously reported the affinity purification of hK2 heterologously expres
Autor:
Pavel Tsinberg, Tony J. Pircher, Farideh Z. Bischoff, Tam Pham, Lisa S. Millar, Stephen M. Coutts, Stephen D. Mikolajczyk, Maryam Zomorrodi
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2011 (2011)
Journal of Oncology, Vol 2011 (2011)
Enrichment of rare circulating tumor cells (CTCs) in blood is typically achieved using antibodies to epithelial cell adhesion molecule (EpCAM), with detection using cytokeratin (CK) antibodies. However, EpCAM and CK are not expressed in some tumors a
Autor:
Stephen D. Mikolajczyk, Diksha Katir, Anna Amirkhan, Harry G. Rittenhouse, Harry J. Linton, William J. Catalona, Cindy L. Evans, Kathy M. Marker, Lisa S. Millar
Publikováno v:
Clinical chemistry. 50(6)
Introduction: Pro or precursor forms of prostate-specific antigen (PSA) have emerged as potentially important diagnostic serum markers for prostate cancer detection. Immunoassays were developed to measure specific proPSA forms containing propeptides